[Clinical applications of dosing algorithm in the predication of warfarin maintenance dose]

Sheng-wen Huang1, Dao-kang Xiang, Bang-quan An

  • 1Department of Laboratory Medicine, Guizhou Provincial People's Hospital, Guiyang, China. hsw713@sina.com

Zhonghua Yi Xue Za Zhi
|February 16, 2012
PubMed

Insights

A genetic-based warfarin dosing algorithm improved warfarin stability in Chinese patients. This approach may shorten the time to reach a stable warfarin dose, demonstrating clinical feasibility.

Area of Science:

  • Pharmacogenomics
  • Clinical Pharmacology

Background:

  • Warfarin dosing requires careful management due to its narrow therapeutic index.
  • Genetic factors, including VKORC1 and CYP2C9 polymorphisms, significantly influence warfarin metabolism and response.
  • Optimizing warfarin dosing is crucial for patient safety and treatment efficacy.

Purpose of the Study:

  • To assess the clinical feasibility of a genetic-based dosing algorithm for predicting warfarin maintenance dose in a Chinese population.
  • To evaluate the impact of a pharmacogenomic dosing strategy on the time to achieve a stable international normalized ratio (INR).

Main Methods:

  • A cohort of 126 patients undergoing heart valve replacement were enrolled.
  • VKORC1 and CYP2C9 genotypes were determined using PCR and melting curve analysis.
  • Patients were randomized into a study group (genetically guided dosing) and a control group (standard dosing).
  • Warfarin doses were adjusted based on measured INR values, with follow-up for 50 days.

Main Results:

  • The proportion of patients achieving a stable warfarin dose within 50 days was higher in the study group (82.4%) compared to the control group (62.5%).
  • The mean duration to reach a stable warfarin dose was significantly shorter in the study group (27.5 days) versus the control group (34.7 days) (P=0.012).
  • The hazard ratio for reaching a stable dose was 1.786 in the study group, indicating a faster achievement of therapeutic stability.

Conclusions:

  • A predicted dosing algorithm incorporating genetic and non-genetic factors can shorten the time to achieve a stable warfarin dose.
  • The study validates the clinical feasibility of using a genetic-based dosing algorithm for warfarin therapy in the Chinese population.
Abstract

Related Concept Videos

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...